The Registry of Toxic Effects of Chemical Substances
Toluene, 2,6 - dinitro - |
UPDATE: October 2002 | MW: 182.15 | MF: C7H6N2O4 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
skin | rabbit
500 mg/24 hour
|
mild
|
NTIS** AD-B011-150
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
body fluid assay
|
mouse
| Salmonella typhimurium
75 mg/kg
|
CALEDQ 52,13,1990
|
body fluid assay
|
rat
| Salmonella typhimurium
75 mg/kg
|
CALEDQ 52,13,1990
|
cytogenetic analysis
|
oral | rat
1,260 mg/kg/6 week- continuous
|
NTIS** AD-A062-015
|
DNA adduct
|
skin | mouse
192 µmol/kg
|
CRNGDP 5,231,1984
|
DNA adduct
|
intraperitoneal | rat
219 µg/kg
|
MUREAV 301,79,1993
|
DNA adduct
|
oral | rat
10 mg/kg
|
JTEHD6 11,555,1983
|
DNA damage
|
rat
liver
|
3 mmol/L
|
SinJF# 26OCT1982
|
DNA inhibition
|
intraperitoneal | rat
20 mg/kg/8 week- intermittent
|
CBTOE2 7,111,1991
|
unscheduled DNA synthesis
|
rat
other cell types
|
10 µmol/L
|
CBTOE2 7,111,1991
|
unscheduled DNA synthesis
|
oral | rat
5 mg/kg
|
CRNGDP 3,241,1982
|
mutation in microorganisms
|
Salmonella typhimurium
|
100 µg/plate (+enzymatic activation step)
|
DTESD7 2,249,1977
|
mutation in microorganisms
|
Salmonella typhimurium
|
1 mg/plate (-enzymatic activation step)
|
SAIGBL 29,34,1987
|
morphological transform
|
oral | rat
58,800 µg/kg/3 week- continuous
|
CRNGDP 7,1797,1986
|
other mutation test systems
|
oral | rat
10 mg/kg
|
JTEHD6 11,555,1983
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 2,555 mg/kg/1 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
JJIND8 79,1313,1987
|
oral | rat
toxic dose : 5,110 mg/kg/1 year- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors
PAACA3 24,91,1983
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lethal concentration (50 percent kill): 240 mg/m3/6 hour
|
Behavioral: General anesthetic | Lung, Thorax, or Respiration: Fibrosing alveolitis Lung, Thorax, or Respiration: Changes in lung weight
NTIS** OTS0533663
|
oral | mouse
lethal dose (50 percent kill): 621 mg/kg
|
Behavioral: Somnolence (general depressed activity)
|
NTIS** AD-A080-146
|
oral | rat
lethal dose (50 percent kill): 177 mg/kg
|
N/R
|
NTIS** PB214-270
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | dog
lowest published toxic dose: 9 gm/kg/90 day- continuous
|
Blood: Normocytic anemia | Blood: Methemoglobinemia- Carboxhemoglobinemia Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 37,116,1976
|
oral | mouse
lowest published toxic dose: 27 gm/kg/90 day- continuous
|
Blood: Normocytic anemia | Blood: Methemoglobinemia- Carboxhemoglobinemia Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 37,116,1976
|
oral | rat
lowest published toxic dose: 13,500 mg/kg/90 day- intermittent
|
Blood: Normocytic anemia | Blood: Methemoglobinemia- Carboxhemoglobinemia Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 37,116,1976
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 65,309,1996
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 65,309,1996
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2B
|
IMEMDT 65,309,1996
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - UNITED KINGDOM
|
Carcinogen, SEP2000
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO 2,6-DINITROTOLUENE-air
|
Carcinogen; | 10 hour time-weighted average 1.5 mg/m3 (Sk)
NIOSH* DHHS #92-100,1992
|
|
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/122004)
|
EPA GENETOX PROGRAM 1988, Inconclusive: CHO gene mutation
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN #44
|
|
REFERENCES:
CODEN
|
|
REFERENCE
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CBTOE2
|
Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279,
Princeton, NJ 08540) V.1- 1984-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
DTESD7
|
Developments in Toxicology and Environtal Science. (Elsevier Science, New York, NY) V.1-15,
1977-87. Discontinued
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
JJIND8
|
JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For
publisher information, see JNCIEQ.
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
PAACA3
|
Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston
St., Baltimore, MD 21202) V.1- 1954-
|
SAIGBL
|
Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu
Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959-
|
SinJF#
|
Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point,
PA 19486, Oct. 26, 1982
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
|